Brooklyn Investment Group Purchases 406 Shares of Colgate-Palmolive (NYSE:CL)

Brooklyn Investment Group raised its position in Colgate-Palmolive (NYSE:CL) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,159 shares of the company’s stock after purchasing an additional 406 shares during the period. Brooklyn Investment Group’s holdings in Colgate-Palmolive were worth $536,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $25,000. Continuum Advisory LLC grew its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth about $53,000. Finally, Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.37% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday. Piper Sandler started coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective on the stock. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Price Performance

Shares of CL opened at $95.34 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company’s fifty day simple moving average is $97.90 and its 200 day simple moving average is $98.58. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company has a market cap of $77.89 billion, a price-to-earnings ratio of 27.32, a PEG ratio of 3.39 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.10%. Colgate-Palmolive’s payout ratio is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.